Atlas Trials

Bacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection

Clinical trial NCT04152161 · TERMINATED

Trial details

NCT number
NCT04152161
Sponsor
Gates Medical Research Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Tuberculosis
Start date
2019-10-16
Primary completion
2024-05-14
Enrollment
1836

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.